Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech Teams with Hungarian University

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Kreatech Diagnostics will partner with Semmelweis University in Budapest, Hungary, to develop new biosample handling methods for use with microarrays.

The company said on Thursday that it will work with the University's 1st Department of Pathology and Experimental Cancer Research to co-develop new micromethods for handling limited amounts of biological samples for microarray analysis.

Amsterdam-based Kreatech said that it will develop a specific methodology that will work with its Universal Linkage System and will be used for processing very limited amounts of formalin-fixed paraffin-embedded samples for array comparative genomic hybridization.

The micromethods will be used in biopsies, laser capture of microdissected cells, and fine needle aspiration.

Also under the partnership, Semmelweiss, which has a large tissue repository, will define putative biomarkers for certain tumor types, and Kreatech will develop and manufacture the corresponding DNA probes for in situ hybridization.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.